Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Imugene names new advisory board members

This article was originally published in Scrip

Executive Summary

Australian biopharmaceutical company Imugene, which develops oncology drugs, has appointed Professor Dr Christoph Zielinski and Professor Dr Ursula Wiedermann to its scientific advisory board. Professor Zielinski is the director of the clinical division of oncology and chair of the department of medicine at the Medical University of Vienna, Austria. He is also coordinator of the comprehensive cancer centre at the university and the General Hospital in Vienna and is president of the Central European Cooperative Oncology Group (CECOG). Meanwhile, Professor Wiedermann is professor of vaccinology and head of the institute of specific prophylaxis and tropical medicine of the Medical University Vienna.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts